🚀 VC round data is live in beta, check it out!

Attana Valuation Multiples

Discover revenue and EBITDA valuation multiples for Attana and similar public comparables like Level Bio, Spermosens, Lumito, Elite Diagnostic and more.

Attana Overview

About Attana

Attana AB offers biologically relevant information to improve efficiency and performance of pharmaceutical drug development.


Founded

2002

HQ

Sweden

Employees

10

Website

attana.com

Financials (FY)

Revenue: $262K
EBITDA: ($939K)

EV

$3M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Attana Financials

Attana reported last fiscal year revenue of $262K and negative EBITDA of ($939K).

In the same fiscal year, Attana generated $342K in gross profit, ($939K) in EBITDA losses, and had net loss of ($1M).


Attana P&L

In the most recent fiscal year, Attana reported revenue of $262K and EBITDA of ($939K).

Attana expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Attana forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$262KXXXXXXXXX
Gross ProfitXXX$342KXXXXXXXXX
Gross MarginXXX131%XXXXXXXXX
EBITDAXXX($939K)XXXXXXXXX
EBITDA MarginXXX(359%)XXXXXXXXX
EBIT MarginXXX(430%)XXXXXXXXX
Net ProfitXXX($1M)XXXXXXXXX
Net MarginXXX(446%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Attana Stock Performance

Attana has current market cap of $2M, and enterprise value of $3M.

Market Cap Evolution


Attana's stock price is $0.00.

See Attana trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3M$2M0.0%XXXXXXXXX$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Attana Valuation Multiples

Attana trades at 9.8x EV/Revenue multiple, and (2.7x) EV/EBITDA.

See valuation multiples for Attana and 15K+ public comps

Attana Financial Valuation Multiples

As of April 8, 2026, Attana has market cap of $2M and EV of $3M.

Equity research analysts estimate Attana's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Attana has a P/E ratio of (2.1x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$2MXXX$2MXXXXXXXXX
EV (current)$3MXXX$3MXXXXXXXXX
EV/RevenueXXX9.8xXXXXXXXXX
EV/EBITDAXXX(2.7x)XXXXXXXXX
EV/EBITXXX(2.3x)XXXXXXXXX
EV/Gross ProfitXXX7.5xXXXXXXXXX
P/EXXX(2.1x)XXXXXXXXX
EV/FCFXXX(3.0x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Attana Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Attana Margins & Growth Rates

Attana's revenue in the last fiscal year declined by (40%).

Attana's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.

See operational valuation multiples for Attana and other 15K+ public comps

Attana Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(40%)XXXXXXXXX
EBITDA MarginXXX(359%)XXXXXXXXX
EBITDA GrowthXXX89%XXXXXXXXX
Revenue per EmployeeXXX$0.0MXXXXXXXXX
Opex per EmployeeXXX$0.1MXXXXXXXXX
Opex to RevenueXXX561%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Attana Public Comps

See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Level BioXXXXXXXXXXXXXXXXXX
SpermosensXXXXXXXXXXXXXXXXXX
LumitoXXXXXXXXXXXXXXXXXX
Elite DiagnosticXXXXXXXXXXXXXXXXXX
NanoEchoXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Attana M&A Activity

Attana acquired XXX companies to date.

Last acquisition by Attana was on XXXXXXXX, XXXXX. Attana acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Attana

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Attana Investment Activity

Attana invested in XXX companies to date.

Attana made its latest investment on XXXXXXXX, XXXXX. Attana invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Attana

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Attana

When was Attana founded?Attana was founded in 2002.
Where is Attana headquartered?Attana is headquartered in Sweden.
How many employees does Attana have?As of today, Attana has over 10 employees.
Is Attana publicly listed?Yes, Attana is a public company listed on Nasdaq Global Market.
What is the stock symbol of Attana?Attana trades under ATANA ticker.
When did Attana go public?Attana went public in 2018.
Who are competitors of Attana?Attana main competitors are Level Bio, Spermosens, Lumito, Elite Diagnostic.
What is the current market cap of Attana?Attana's current market cap is $2M.
What is the current revenue of Attana?Attana's last fiscal year revenue is $262K.
What is the current EV/Revenue multiple of Attana?Current revenue multiple of Attana is 9.8x.
Is Attana profitable?No, Attana is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial